This research evaluates the antibacterial potential of novel chromane analogues, implying significant implications for medicinal chemistry.
Because of its diverse variety of pharmacological effects, chromane (4H-benzopyran) is a privileged scaffold in medicinal chemistry. In order to increase antibacterial activity, new chromane-based analogues were created and synthesised for this investigation. The produced compounds' antibacterial ability was assessed against a range of bacterial and fungal strains, and their structural characteristics were assessed through the use of spectroscopic techniques. Significant antibacterial activity was demonstrated by a number of compounds, suggesting that they could be excellent leads for more research. Numerous new compounds based on chromane were created and demonstrated encouraging antibacterial properties. Changes in structure have a major impact on potency. These results serve as a foundation for additional chromane analogue research and optimisation as possible antibacterial agents.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: